Immunicum AB (publ)
Immunicum AB (publ) meddelar förändringar i ledningsgruppen efter sammanslagningen
March 16, 2021 03:30 ET | Immunicum AB
Pressmeddelande 16 mars 2021  Immunicum AB (publ) meddelar förändringar i ledningsgruppen efter sammanslagningen Immunicum AB (publ; IMMU.ST) meddelar idag förändringar i bolagets ledningsgrupp...
Immunicum AB (publ)
Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination
March 16, 2021 03:30 ET | Immunicum AB
Press Release 16 March 2021  Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination Immunicum AB (publ; IMMU.ST) announced today the establishment of an updated...
Immunicum AB (publ)
Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef
March 01, 2021 02:00 ET | Immunicum AB
Pressmeddelande 1 mars 2021 Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef Immunicum AB (publ; IMMU.ST) meddelar idag att Jeroen Rovers, M.D., Ph.D. har utsetts...
Immunicum AB (publ)
Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief Medical Officer
March 01, 2021 02:00 ET | Immunicum AB
Press Release 1 March 2021 Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief Medical Officer Immunicum AB (publ; IMMU.ST) announced today that Jeroen Rovers, M.D., Ph.D., has...
Immunicum meddelar l
Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer
February 22, 2021 02:00 ET | Immunicum AB
Pressmeddelande 22 februari 2021 Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer - Medianöverlevnad för patientgruppen som behandlades...
Immunicum Announces
Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer
February 22, 2021 02:00 ET | Immunicum AB
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer -- Median Overall Survival (OS) for the...
Immunicum AB (publ)
Immunicum AB (publ) publicerar bokslutskommuniké 2020
February 18, 2021 02:00 ET | Immunicum AB
Pressmeddelande 18 februari 2021 Immunicum AB (publ) publicerar bokslutskommuniké 2020 OKTOBER - DECEMER I SAMMANDRAG Nettoomsättning för kvartalet uppgick till - (-)*.Periodens resultat...
Immunicum AB (publ)
Immunicum AB (publ) Announces Year-End Results 2020
February 18, 2021 02:00 ET | Immunicum AB
Press Release 18 February 2021 Immunicum AB (publ) Announces Year-End Results 2020 OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK – (-)*.Result for the...
Immunicum AB (publ)
Immunicum AB (publ) meddelar att Lotta Ferm har utsetts till ny tillförordnad finanschef
February 01, 2021 11:45 ET | Immunicum AB
Pressmeddelande 1 februari 2021 Immunicum AB (publ) meddelar att Lotta Ferm har utsetts till ny tillförordnad finanschef Immunicum AB (publ; IMMU.ST) meddelar idag att Lotta Ferm kommer att...
Immunicum AB (publ)
Immunicum AB (publ) Announces New Interim CFO Lotta Ferm
February 01, 2021 11:45 ET | Immunicum AB
Press Release 01 February 2021 Immunicum AB (publ) Announces New Interim CFO Lotta Ferm Immunicum AB (publ; IMMU.ST) announced today that effective immediately, Lotta Ferm will join the leadership...